 |
| Heike Galbraith |
Heike Galbraith, who was GCI Health's European policy & PA head, has joined Dentons Global Advisors as a partner based in Brussels.
During her more than 20-year career, Galbraith gained experiences in therapeutic areas including vaccines, oncology, rare diseases, HIV/AIDS and hepatitis.
She did a 12-year stint at Pfizer as director of the global rare disease & vaccines PA team, and head of EU government affairs.
Earlier, Galbraith was director of international government affairs at Gilead and staffer at Burson-Marsteller.
"Heike brings fresh insight and corporate experience on some of the most critical health policy issues facing companies that are looking to make a positive contribution to society," said Grégoire Poisson, CEO of Dentons Global Advisors Interel, the firm's EU PA arm.
Jim Weiss, founder & chairman of Real Chemistry, has joined the board of ICR Inc. as it steps up its healthcare capital markets offering.
Ruder Finn has hired Kelly Yoder, who spent a dozen years at Weber Shandwick rising to North America health lead, as managing director, global head of health & life sciences.
ICR has named John Capodanno head of US healthcare corporate communications and Matthew Willey managing director in its medical technology and diagnostics practice. 
April is National Minority Health Month, spotlighting the urgency to improve health outcomes in communities of color.
In a recent conversation about the evolving media landscape, Doug Simon, CEO of D S Simon Media, spoke with Campbell O’Connor, Group Director, Media & Engagement at Real Chemistry, about how AI is influencing media relations and healthcare communications.
